Biologics is a Sinking Ship - Recensione dipendente - Business Development Manager presso Curia

1,0
14 mar 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Was able to negotiate a competitive base salary.

Svantaggi

In my opinion the LakePharma acquisition was a mistake and management never really understood what they were buying. In September 2021 6 sites and 235 employees joined but 2.5 years later only 2 sites remain open with maybe 75 people. This extreme cost cutting means no investment in innovation or instrumentation and most work is being done by hand. High prices, increasing competition, and a lack of leadership have resulted in an underperforming business. For a 3300+ person company the marketing department is a joke HIGH TURNOVER in all departments = HUGE RED FLAG Private Equity owners = only care about profits and will likely close or sell off more sites this year Talk with some former employees before accepting a job

avatar
Risposta di Curia
2y
Thank you for your review. We take all feedback into consideration when planning for the future and all reviews, like yours, are critical to our ability to implement change. We appreciate you taking the time to share about your experience.

Esplora altre recensioni su Curia

5,0
28 ago 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great team and great work being done at Curia

Svantaggi

Salary is not high enough I think

5,0
25 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great team, exciting science, growth opportunities

Svantaggi

Managing growth in difficult economic conditions

Vedi recensioni per: Utile|Valutazione|Data|Tutto